• Actions of Protein Glues revealed by MS
    Picture Credit: University of Birmingham

News & Views

Actions of Protein Glues revealed by MS

Jun 20 2023

A commonly used screening technique in drug discovery has now been successfully applied to yield important details about the actions of molecular ‘glues’ that are emerging as powerful therapeutic tools with capability to stick proteins together in the body.

Interactions between proteins underpin all biological cell functions, including those of disease, so interventions that can control protein-protein interactions have significant potential for disrupting the progress of various diseases.

While in many cases, drugs are required to interrupt the processes that connect proteins together, there are also occasions when the intervention is needed to restore an interaction, or to make it function correctly.

Researchers at the University of Birmingham, together with partners at the University of Leicester and the Eindhoven University of Technology, have used mass spectroscopy (MS) to analyse candidate glues for these processes and assess their relative strengths.

Dr Aneika Leney, of the School of Biosciences at the University of Birmingham, explained: “Often when we are designing new drugs, it is to stop harmful protein interactions in the body, such as those that lead to tumour cell growth in cancers. Sometimes, however, the disease is caused by protein interactions falling apart and in these cases finding the right glue to hold them together could be extremely beneficial.”

In a study* focused on one particular molecular glue MG1, the research team used MS to unravel the different mechanisms through which the glue bound to the proteins and stabilised the protein interaction. The MS method also allowed the researchers to elucidate the relative time taken by the different processes involved.

Dr Peter Cossar, from the Department of Biomedical Engineering at Eindhoven University of Technology further explained: “Understanding how molecular glues stick proteins together enables scientist to better design and build the next generation of molecular glue drugs. Mass Spectrometry provides a tool to do so, by providing high fidelity information on how these unique molecules behave in real time.”

The team expect that the research will provide a robust framework for testing a wide range of molecular glues, offering a significant advance in drug discovery understanding in this area.

*Published in Chemical Science.

More information online

Digital Edition

MAC Guide 2023/24

December 2023

Buyers Guide - Major producers of analytical equipment who wish to introduce and sell their products to buyers in science and industry - Over 1,000 products and services that these companys man...

View all digital editions


Instrumentation Live

Jan 17 2024 Birmingham, UK

Smart Factory Expo 2023

Jan 24 2024 Tokyo, Japan

Arab Health

Jan 29 2024 Dubai, UAE

Nano Tech 2024

Jan 31 2024 Tokyo, Japan

SLAS 2024

Feb 03 2024 Boston, MA, USA

View all events